Pfizer to buy Biohaven Pharma in $11.6 billion deal
Pfizer will acquire all the outstanding shares of Biohaven not already owned by Pfizer for $148.50 per share in cash, a 78.6 per…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.